Prior to the pandemic, hospitals were marching toward solutions that paid homage to the heads-and-beds model, with its tight margins. They were investing in specialists to bring elective surgeries in-house. They were becoming more efficient on th...

For the past year a parade of news has crossed my desk on the wonders of telehealth. If you're someone who sees a doctor on a periodic basis only, it's been a fantastic option for saving time, money, even hassle.

Yet it's also e...

Pounded by both sides of the political aisle, pharmaceutical companies know what it feels like to be whipsawed by opposite ends of the American reimbursement system.

Two weeks after the November election, President Trump announced a n...

Life sciences companies tend to consider themselves leaders when it comes to compliance policies.

In one sense they're right. The close sales relations between their distribution agents and state-linked doctors and hospitals have lo...